Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252833 · ClinicalTrials.gov registry record · Phase 1
Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers
A Phase 1 study, sponsored by Lotus Clinical Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04252833 is a Phase 1 study that has completed, run by Lotus Clinical Research. The registered enrollment target is 10 participants.
The verdict
NCT04252833, a Phase 1 study, has completed, sponsored by Lotus Clinical Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.
Interventions
- DRUG CT-044
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2020-03-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04252833
The ClinicalTrials.gov registry entry for NCT04252833 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lotus Clinical Research, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CT-044 is the first listed.
NCT04252833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04252833 about?
NCT04252833 is a clinical study titled "Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers". This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.
What is the current status of trial NCT04252833?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2020-02-18. Estimated completion is 2020-03-16.
What interventions are being tested in trial NCT04252833?
The interventions under investigation include: CT-044 (DRUG).
Who is sponsoring clinical trial NCT04252833?
This trial is sponsored by Lotus Clinical Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.